Rossari Biotech Ltd
NSE:ROSSARI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
567.75
831.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Rossari Biotech Ltd
Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 451 full-time employees. The company went IPO on 2020-07-23. The firm provides customized solutions to industrial and production requirements of its customers through its diversified product portfolio. The company builds its expertise from textiles and has diversified into the animal health and nutrition, home, personal care and performance chemicals markets. The company offers a range of sustainable products for pre-treatment, dyeing, printing, finishing processes, and specialty chemicals. The firm provides specialty chemical solutions across the entire value-chain of the textile industry starting from thread, yarn and man-made fiber production to digital printing, fabric processing, dyeing auxiliaries and garment finishing range. The company develops product portfolio for its businesses of home, personal care and performance chemicals. The firm operates two manufacturing facilities at Silvassa and Dahej.
Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 451 full-time employees. The company went IPO on 2020-07-23. The firm provides customized solutions to industrial and production requirements of its customers through its diversified product portfolio. The company builds its expertise from textiles and has diversified into the animal health and nutrition, home, personal care and performance chemicals markets. The company offers a range of sustainable products for pre-treatment, dyeing, printing, finishing processes, and specialty chemicals. The firm provides specialty chemical solutions across the entire value-chain of the textile industry starting from thread, yarn and man-made fiber production to digital printing, fabric processing, dyeing auxiliaries and garment finishing range. The company develops product portfolio for its businesses of home, personal care and performance chemicals. The firm operates two manufacturing facilities at Silvassa and Dahej.
Revenue Growth: Q2 FY '26 revenue grew 18% year-on-year, driven by strong volume gains across key business segments.
Segment Performance: HPPC, Textile Specialty Chemicals, and Animal Health & Nutrition divisions grew 16%, 21%, and 29% YoY, respectively, with export revenues up 36% YoY.
Profitability: EBITDA margin stood at 12.3%, down from 13.2% last year, with management citing subdued pricing and ongoing investments as reasons.
Capacity Expansion: New manufacturing capacities were commissioned at Dahej and Unitop, with further expansions progressing and expected to boost future revenue and margin.
Export Momentum: Exports now contribute 28% of revenue, with growth driven by deeper penetration in Far East, Southeast Asia, and MENA regions.
Cost Pressures: Other expenses rose due to higher freight, travel, and maintenance; some costs are one-time, but freight may remain elevated due to tariffs.
Working Capital: Net working capital days increased to 102, mainly due to stretched receivables, but management expects normalization in coming quarters.
Margin Outlook: Core B2B EBITDA margin guided to remain at 14–16%, with broader margins expected to stay stable for the rest of FY '26.
